Free Trial

Insider Selling: Exponent, Inc. (NASDAQ:EXPO) VP Sells 1,573 Shares of Stock

Exponent logo with Business Services background

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Exponent Trading Down 0.8%

Shares of Exponent stock traded down $0.61 on Friday, reaching $76.63. 520,186 shares of the stock were exchanged, compared to its average volume of 249,106. Exponent, Inc. has a 1-year low of $73.37 and a 1-year high of $115.75. The business has a fifty day moving average price of $78.46 and a two-hundred day moving average price of $86.26. The firm has a market capitalization of $3.89 billion, a PE ratio of 36.15 and a beta of 0.95.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The business had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. During the same period in the previous year, the business posted $0.59 earnings per share. The business's revenue was up .2% compared to the same quarter last year. Research analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.57%. Exponent's dividend payout ratio (DPR) is 58.54%.

Institutional Trading of Exponent

A number of institutional investors have recently added to or reduced their stakes in EXPO. Raymond James Financial Inc. purchased a new stake in Exponent during the fourth quarter worth about $55,131,000. Norges Bank purchased a new stake in Exponent during the fourth quarter worth about $52,381,000. Resona Asset Management Co. Ltd. purchased a new stake in Exponent during the fourth quarter worth about $38,538,000. Millennium Management LLC boosted its holdings in Exponent by 543.1% during the first quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock worth $24,742,000 after buying an additional 257,766 shares in the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new stake in Exponent during the first quarter worth about $15,349,000. Hedge funds and other institutional investors own 92.37% of the company's stock.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines